Explore evidence

1,800,000 personsIn 2018, an estimated 1.8 million persons living in Nigeria had HIV infection, representing 1.3% of the total population.

NigeriaVIH/sidaobserved 2018published 2021MMWR. Morbidity and mortality weekly reportPubMeddocument of 6 observations

Next Generation Sequencing on 1st of October revealed one full and two partial RHDV2 genomes on both farms in Ibadan, Nigeria.

NigeriaRHDV2observed 2020-10-01published 2020Microbial Metagenomic Approach Uncovers the First Rabbit Haemorrhagic Disease Virus genomeeurope_pmcdocument of 5 observationsDOI 10.1101/2020.11.19.390559

0.403 correlation_coefficientThere was a significant positive correlation between awareness of low malaria transmission and malaria diagnosis (r = 0.403, P < 0.001).

Nigeriapaludismepublished 2025Scientific reportsPubMeddocument of 14 observations

44.2 %Among 240 booked pregnant women in Oyo state, 44.2% of HIV-negative respondents reported being abused in the index pregnancy.

NigeriaVIH/sidaobserved 2019published 2023Journal of the International Association of Providers of AIDS CarePubMeddocument of 6 observations

95 %Greater than 95% of pre-treatment parasitaemia was cleared by 24 hours after commencement of treatment in all groups.

Nigeriapaludismepublished 1996Acta tropicaeurope_pmcdocument of 8 observations

10,015 participantsA total of 10015 participants representing 14.4% of ART clients in 50 hospitals opted for the community pharmacy ART refill model.

NigeriaVIH/sidaobserved October 2016 to February 2018published 2021Research in social & administrative pharmacy : RSAPPubMeddocument of 6 observations

11.8 %Among PLHIV aged 51–60 years, the prevalence of HBeAg was 11.8%.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

11.1 %Cord blood malaria parasitaemia prevalence was 11.1%.

Nigeriapaludismepublished 2026Parasitology internationalPubMeddocument of 8 observations

2,500 NGNThe median maximum amount people living with HIV (PLHIV) on antiretroviral therapy (ART) were willing to pay for viral load testing services was NGN2,500 (USD $6.94), with an interquartile range of NGN1,000–NGN5,000.

NigeriaVIH/sidaobserved July and August 2019published 2023PloS onePubMeddocument of 9 observations

18.2 %18.2% of the women cited not feeling susceptible to cervical cancer as a reason for not being screened.

Nigeriacancer du col de l'utéruspublished 2021The Pan African medical journalPubMeddocument of 8 observations

99.12 %Viral suppression was 99.12%.

NigeriaVIH/sidaobserved October 2016 to February 2018published 2021Research in social & administrative pharmacy : RSAPPubMeddocument of 6 observations

13.9 %Among male PLHIV participants, the prevalence of HBsAg was 13.9%.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

55.09 %Diabetic foot ulcers predominantly affected the left foot in 55.09% of cases in Nigeria.

Nigeriapied diabétiquepublished 2026Journal of epidemiology and global healthPubMeddocument of 12 observations

55.4 %The prevalence of elevated total cholesterol among respondents was 55.4%.

Nigeriaelevated total cholesterolpublished 2020BMC cardiovascular disordersPubMeddocument of 11 observations

20.38 %The prevalence of diabetic foot ulcers was highest in the Southwest region of Nigeria at 20.38%.

Nigeriapied diabétiquepublished 2026Journal of epidemiology and global healthPubMeddocument of 12 observations

Patients without periprosthetic joint infection recorded statistically significant improvement in Visual Analogue Scale score (p = 0.000) at three months.

Nigeriaperiprosthetic joint infectionobserved three monthspublished 2026Journal of ISAKOS : joint disorders & orthopaedic sports medicinePubMeddocument of 3 observations

63.3 %Mefloquine produced a parasite reduction of 63.3% at 24 hours.

Nigeriapaludismepublished 1996Annals of tropical paediatricseurope_pmcdocument of 6 observations

17 deathsSeventeen (1.4%) patients with sickle cell disease and respiratory morbidities died.

Nigeriadrépanocytose · respiratory morbiditiesobserved 2012 to 2021published 2024PloS onePubMeddocument of 12 observations

21 casesTwenty-one (95.5%) high risk infants had their first PCR screening between 3 and 14 months.

NigeriaVIH/sidapublished 2025West African journal of medicinePubMeddocument of 8 observations

35.4 scoreThe post-intervention overall symptom domain score was 35.4 ± 12.4 for the control group.

Nigeriacancer du seinpublished 2021Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 8 observations

1.57 adjusted_odds_ratioDuration of illness >3 days was an independent risk factor for the presence of gametocytaemia at enrolment with adjusted odds ratio = 1.57.

Nigeriapaludismepublished 2004Parasitologyeurope_pmcdocument of 10 observations

24.3 %Rifampicin resistance was observed in 9 out of 37 (24.3%) HIV-positive tuberculosis patients in the North Central zone of Nigeria.

Nigeriatuberculose · VIH/sidapublished 2019Journal of epidemiology and global healthPubMeddocument of 7 observations

37 %The pooled prevalence of cervical papillomavirus infection was 37% among women living with HIV/AIDS in Nigeria.

Nigeriainfection à HPVpublished 2020Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 2 observations

33.4 %The overall prevalence of hypertension was 33.4% among the 1460 participants from four communities situated at varying distances from the refinery.

Nigeriahypertension artériellepublished 2025Nigerian journal of clinical practicePubMeddocument of 6 observations

2,124 casesIn Nigeria, there were 2,124 cholera cases and 68 deaths from January 2025 to July 2025.

Nigeriacholéraobserved Jan 2025 – 31 July 2025Africa CDCdocument of 176 observations